BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210908T133000
DTEND;TZID=Europe/London:20210908T160000
DTSTAMP:20260421T222838
CREATED:20210812T093121Z
LAST-MODIFIED:20210812T093121Z
UID:18754-1631107800-1631116800@staging.medilinkmidlands.com
SUMMARY:VIRTUAL: Fourth Annual Conference on Innovation & Trade: Mentor Means Business
DESCRIPTION:The Northeast Ohio region is home to some of the leading medical institutions in the United States\, including the Cleveland Clinic\, and the region has developed one of the nation’s most important biomedical clusters. \nOver 700 biomedical firms are located there\, including over 400 medical device manufacturers specialising in imaging\, neuro-stimulation\, orthopaedics\, cardiovascular\, and sterilisation. \nInternationally recognised clinical research institutions\, including the prestigious Cleveland Clinic\, University Hospitals\, and Case Western Reserve University\, provide Mentor biomedical and med-tech companies a world-class platform for research\, design\, and innovation. \nOn 8 September\, 2021\, learn more about the advantages of doing business in Northeast Ohio and the City of Mentor by participating in a virtual conference focused on Ohio’s medtech innovation corridor. \nConference activities include: \n– Discussion with experienced legal advisors on setting up your US business operations and positioning your company for success in the North American market\n– Guidance from high-level US hospital system personnel on the particulars of getting your products and services into the US healthcare system\n– Direct interaction and potential dialogue with US companies and officials that can help you bring your products and services into the United States \nView the programme and further details here\nTo register online\, click here
URL:https://staging.medilinkmidlands.com/event/mentor-means-business-fourth-annual-conference-on-innovation-trade-virtual/
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210909T090000
DTEND;TZID=Europe/London:20210909T130000
DTSTAMP:20260421T222838
CREATED:20210804T073810Z
LAST-MODIFIED:20210804T073810Z
UID:18743-1631178000-1631192400@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: IP Strategy for Medical Devices
DESCRIPTION:  \n[box type=”shadow” align=”” class=”” width=””]\nWith COVID-19 restrictions being eased for business events\, we are pleased to be able to offer this in person event.  Please see details below regarding COVID-19 compliance. \n[/box] \n \nAttend this event to hear from AdamsonJones\, limited spaces available – book early to avoid disappointment. \nThis event has been designed for companies developing innovative medical devices to learn how to navigate complex patent landscapes in the medical devices sector and to learn about strategies for increasing the value of their own patent applications and other IP. \nTopics include:\n– Patent searches and R&D\n– Navigating patent landscapes\n– Identifying inventive concepts\n– Patent filing strategies\n– Attracting investment\n– Enforcement\n– Design registrations\n– Trade marks \nProgramme \nSpeaker Profiles \nDelegate List \nThe venue and all participants will be required to adhere to social distancing guidelines at all times. Please see further information below regarding COVID-19 compliance at the venue. \nWe are Pioneer Group\, Nottingham (formerly BioCity): \nWe are Pioneer Group is accessible by car\, train and bus as it is a City Centre venue\, on-site parking is not available for delegates\, however the Motorpoint Arena Car park is available and located behind the buildings\, for details and the address see here. \nVenue and event – COVID-19 Compliance\n– Delegates must not attend if they are self isolating or displaying any COVID-19 symptoms (a high temperature\, new and persistent cough\, or a loss of/change in sense of taste or smell)\, even if these symptoms are mild\n– Delegates must not attend if anyone they live with have one of the above symptoms\n– An NHS QR code for delegates to check in on will be available\n– Delegates/staff have the option to wear a face covering upon entering the venue and whilst in attendance at the event\n– The room will be laid out with relevant spacing between tables/delegates\n– All rooms will have hand sanitiser nearby\n– Social distancing measures will be in effect for all toilets\n– Individual boxes will be provided for lunch – with options for Meat eaters\, Vegetarian\, Vegan and Gluten Free
URL:https://staging.medilinkmidlands.com/event/ip-strategy-for-medical-devices/
LOCATION:We are Pioneer Group Nottingham\, Innovation Building\, (formerly BioCity)\, Pennyfoot Street\, Nottingham\, NG1 1GF\, United Kingdom
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final-transparent.png
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210914T100000
DTEND;TZID=Europe/London:20210914T113000
DTSTAMP:20260421T222838
CREATED:20210726T120537Z
LAST-MODIFIED:20210726T120537Z
UID:18718-1631613600-1631619000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: How are you ensuring you're plugging the future skills gap in Life Sciences?
DESCRIPTION:In this Medilink Midlands webinar\, We are Pioneer Group will discuss whether there is a life science skills and infrastructure gap in the Midlands? Where are the opportunities and What can we do about it? \nThe life sciences industry is continuing to boom\, with new technologies and locations changing not only how professionals are working but where. The health and life sciences sector already provides jobs for nearly 256\,000 people across the United Kingdom\, but ongoing growth and strategic transformation means demand for new skills and experienced personnel is only expected to grow in the coming years. \nCould this mean a life science skills and infrastructure gap for the Midlands? What can we do as a collective to prepare? \nThe webinar will address: \n-How we can ensure we have the talent in place – from clinical pharmacologists\, to bioinformaticians to innovators in medicine development?\n-How do we capitalise on the hubs we already have for working in and what’s needed in the future?\n-What infrastructure is missing? \nPresentations will be followed by a Q&A session. \nSpeaker Profiles: \n \n  \n  \n  \n  \n  \nToby Reid\, Executive Director\, We are Pioneer Group (Chair)\nToby has managed and run life science-focused properties and ecosystems for the last ten years. He has a background in engineering and project management as well as business start-up and venture capital finance. Toby leads on creating the environment that helps tenant companies scale and grow. \n \n  \n  \n  \n  \n  \n  \n  \nProfessor Mike Hannay\, Managing Director\, Medical Technologies Innovation Facility (MTIF)\nMike is Managing Director of MTIF based in Nottingham.  Funded by Nottingham Trent University and D2N2 Local Enterprise Partnership MTIF works with partners across the East Midlands to improve the quality of patient care by helping Med-Tech companies accelerate the development and commercial availability of innovative medical technologies and devices. \n \n  \n  \n  \n  \n  \n  \n  \n  \nProfessor Claire Thompson\, CEO\, Agility Life Sciences\nClaire is a multi-award winning scientist\, strategist and storyteller with more than 20 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer\, virtual biotech and Contract Development and Manufacturing Organisations (CDMOs). She is CEO of Agility Life Sciences\, an award-winning CDMO\, consulting and communications firm which works with organisations across the healthcare space to fast track their products to market\, raise investment and help them to convey the benefits of their science through impactful communications.\nShe is also Entrepreneur in Residence at the University of Cambridge. Claire holds an Honorary Professorship from the School of Pharmacy at the University of Nottingham\, and is Chair of the International Pharmaceutical Federation’s Women in Science and Education (FIP WiSE) initiative. \n\nRobin Weir\, Head of China Practice\, Facey Associates LLP\, Hong Kong\nManaging Director\, Turkington Tang Limited\nRobin is head of the China practice at Facey & Associates LLP\, a boutique law firm in Hong Kong\, having lived for 13 years in mainland China. He is also managing director of Turkington Tang\, a consultancy which advises on international business including cross-cultural management issues.
URL:https://staging.medilinkmidlands.com/event/webinar-how-are-you-ensuring-youre-plugging-the-future-skills-gap-in-life-sciences/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Claire-Thompson-profile-web.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210915T100000
DTEND;TZID=Europe/London:20210915T110000
DTSTAMP:20260421T222838
CREATED:20210303T160724Z
LAST-MODIFIED:20210303T160724Z
UID:18592-1631700000-1631703600@staging.medilinkmidlands.com
SUMMARY:VIRTUAL WORKSHOP: Creating Valid Evidence & Evaluation for the NHS for Medical Devices
DESCRIPTION:***REGISTRATION FOR THIS EVENT IS NOW CLOSED*** \nJoin the third of our two-part CPD accredited virtual workshops\, Creating Valid Evidence & Evaluation for the NHS for Medical Devices\, delivered by the East Midlands Academic Health Science Network (EMAHSN).  \nThis session will provide an overview about the kinds of evidence and evaluation that the healthcare system really wants in order to support their buying decisions. \nThis is the third part of the 3 session CPD accredited workshop series designed to get you ready to successfully secure business with NHS organisations \nPART 1 is a pre-recorded webinar that you can watch at a time convenient to you. \nThe pre-recorded webinar will cover: \n• Evidence needed for regulatory purposes\n• Principles and models of evaluation and principles of study design for evaluating healthcare interventions\, to outline the value proposition of the innovation \n—————— \nPART 2 is a live 1-hour Q&A session on Wednesday 15th September 10:00am – 11:00am \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \n \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed. \n  \nSPEAKER PROFILES: \nJulian Patel\, Commercial Manager\, East Midlands AHSN \n  \n  \n  \n  \n  \n \nAisha Ajij\, Project Support & Industry Liasion Officer/ITP – AAC Delivery Lead\, East Midlands AHSN \n  \n  \n  \n  \n  \n \n  \nPhilip Miller\, Evaluation Researcher\, East Midlands AHSN \n  \n  \n  \n  \n  \n  \n \nDr Sarah Bolton\, Business Manager\, The Centre for Healthcare Equipment & Technology Adoption (CHEATA) \n  \n  \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/virtual-workshop-creating-valid-evidence-evaluation-for-the-nhs-for-medical-devices-2/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/MM-Badge-for-EMAHSN-Webinars-2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210916T130000
DTEND;TZID=Europe/London:20210916T140000
DTSTAMP:20260421T222838
CREATED:20210729T073506Z
LAST-MODIFIED:20210729T073506Z
UID:18728-1631797200-1631800800@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medtech Regulatory Special Interest Group (SIG) – Product traceability and Unique Device Identification for the EU and Global Use
DESCRIPTION:The next MedTech Regulatory Special Interest Group (SIG)\, delivered by regulatory affairs expert Richard Young and GS1 standards professional Chris Florey\, will explore the requirements for product traceability and Unique Identification for the EU and Global Use\, immediate and future considerations for a business. \nThis webinar will cover: \nRichard Young\, AcclaimBiomedical Consulting Ltd:\n– Regulatory background\n– Eudamed\n– MDCG guidance so far \nChris Florey\, GS1 standards professional\, GS1 UK:\n– Basic UDI DI (GMN)\n– UDI-DI and UDI-PI\n– UDI for software as a medical device\n– Human Readable Interpretation (HRI)\n– Barcode verification \nThere will be time at the end of the presentations for a Q&A session. Please submit any questions in advance for Richard and Chris to discuss during the presentation on the online booking form. \nThis free-to-attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the ACTIS programme\, attendance is not restricted to companies in the SEMLEP area and is open to all. \nDuration: 1 hour \nTO BOOK YOUR FREE PLACE\, CLICK HERE\nSpeaker Profiles: \n \n  \n  \n  \n  \n  \nRichard Young\, Managing Director\, AcclaimBiomedical Consulting Ltd\nRichard has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing)\, and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardio vascular products. \nRichard brings a blend of pragmatism and experience to these disciplines that facilitates insightful problem solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI and ABHI Technical Policy Group. \n\nChris Florey\, GS1 standards professional\, GS1 UK\nChris has over 15 years experience of working with organisations to adopt GS1 standards to meet trading partner and regulatory requirements\, and his focus for the past eight years has been within the healthcare industry\, assisting medical device and pharmaceutical manufacturers in implementing the NHS eProcurement strategy\, the FDA UDI rules\, the EU MDR and the FMD using GS1 standards. Whilst not a regulatory expert\, he is able to share his experience of engaging with the regulators and thousands of manufacturers and distributors that are GS1 UK members.
URL:https://staging.medilinkmidlands.com/event/webinar-medtech-regulatory-special-interest-group-sig-product-traceability-and-unique-device-identification-for-the-eu-and-global-use/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Chris-Florey.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210921T100000
DTEND;TZID=Europe/London:20210921T113000
DTSTAMP:20260421T222838
CREATED:20210809T070122Z
LAST-MODIFIED:20210809T070122Z
UID:18744-1632218400-1632223800@staging.medilinkmidlands.com
SUMMARY:*Cancelled* WEBINAR: The Midlands Ecosystem of Bench to Bedside in the Era of MDR and UKCA
DESCRIPTION:**Unfortunately this event has been cancelled due to unforeseen circumstances. We anticipate that it will take place in early 2022\, details to be released in our fortnightly newsletter in due course**\nThe MedTech and medical devices market for the UK has changed. Companies large and small\, having weathered the impacts of COVID-19\, are now faced with further challenges as the EU’s MDR comes into effect and we march towards the time limit on marketing CE marked devices and in vitro diagnostics within the UK and the introduction of the UKCA. These changes present opportunities but companies will have to be prepared if they are to remain profitable\, whilst both maintaining compliance and in achieving compliance for their new devices and diagnostics. \nFortunately the Midlands boasts a thriving ecosystem of MedTech organisations\, networked to provide end to end support for driving innovations from “bench to bedside”. Companies within the Midlands have a multitude of development services which they can access to help take them from ideation to regulation. This webinar in partnership with the Medical Technologies Innovation Facility (MTIF) aims to highlight these services and map out how to both access them and get the most out of that interaction. \nThere will be an opportunity to put your questions to the presenters in a Q&A session after the presentations. \nDuration 1 hr 30 mins \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2 area and is open to all. \nSpeaker Profiles  \n \nProfessor Mike Hannay\, Managing Director\, Medical Technologies Innovation Facility (MTIF) – CHAIR \nMike is Managing Director of MTIF based in Nottingham.  Funded by Nottingham Trent University and D2N2 Local Enterprise Partnership MTIF works with partners across the East Midlands to improve the quality of patient care by helping Med-Tech companies accelerate the development and commercial availability of innovative medical technologies and devices \n  \n  \n  \n  \n Deanne Hewson\, Healthcare Technologies Industry Manager\, University of Nottingham \nDeanne Hewson has worked with businesses and universities for over 20 years\, developing knowledge exchange activities and providing business support. Deanne’s current role with the Centre for Healthcare Technologies focuses on delivery of the INSTILS programme\, offering support to SMEs in the D2N2 region to innovate products\, services and processes. \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-the-midlands-ecosystem-of-bench-to-bedside-in-the-era-of-mdr-and-ukca/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Deanne-Hewson.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210922T103000
DTEND;TZID=Europe/London:20210922T113000
DTSTAMP:20260421T222838
CREATED:20210811T144154Z
LAST-MODIFIED:20210811T144154Z
UID:18747-1632306600-1632310200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Additive Manufacturing & 3D Printing Special Interest Group (SIG)
DESCRIPTION:Join the next online Additive Manufacturing & 3D Printing Special Interest Group\, in partnership with The University of Nottingham – Centre for Additive Manufacturing. \nConfirmed presentation topics: \n– Medical Product Design for Additive Manufacturing\n– How to protect Intellectual Property in Additive Manufacturing innovations\n– Additive Manufacturing of Medical Devices \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2 area and is open to all. \nSpeaker Profiles: \n\nChaired by: Ruth Goodridge\, Professor in Additive Manufacturing (3D Printing)\, The University of Nottingham \nRuth is Professor of Additive Manufacturing (3D-Printing) at the University of Nottingham. She is currently on secondment to Nottingham University Hospitals NHS Trust\, based in Clinical Engineering. With a degree in Biomaterials and PhD in Bioengineering\, she has a particular interest in the medical applications of Additive Manufacturing\, including assistive and rehabilitation devices (inc. prosthetics)\, implants and diagnostics. She has 20 years experience in multidisciplinary research into Additive Manufacturing\, including a 2-year JSPS fellowship held at NAIST\, Japan. Her expertise lies in material development for AM and advancing understanding of coupled material-processing aspects\, in particular for polymer and glass powder bed fusion. \n\nProfessor Richard Bibb\, Professor of Medical Applications of Design\, School of Design & Creative Arts – Loughborough University\nRichard is Professor of Medical Applications of Design in the School of Design & Creative Arts\, Loughborough University. He has more than 20 years’ experience in research exploring the application of Additive Manufacturing and advanced design technologies in surgery\, prosthetics\, orthotics and medical devices. He founded the Medical Applications Group at PDR in 1998 and led it for 10 years. He moved to Loughborough University in 2008 and founded the Digital Design & Fabrication research group in 2014. \n \nGareth Probert\, Partner\, UK and European Patent Attorney\, EIP\nGareth is a partner at the patent firm EIP and heads the EIP HealthTech practice group\, an interdisciplinary team specialising in protecting innovations in the medtech and healthcare sectors. He also focusses on contentious proceedings before the European Patent Office\, often handling multi-party oppositions for commercially significant patents. During his 20-year career in the profession Gareth has gained substantial experience in the medtech and healthcare space\, along with the FMCG\, formulations\, peptide\, food and chemical sectors. \n\nDimitris Katsanis\, Founder & CEO\, Metron Additive Engineering\nDimitris is the founder and CEO of Metron Additive Engineering\, an ISO 13485 and AS9100 certified company\, active in the field of Additive Manufacturing of metallic components.\nSince 2015\, he leads a team of engineers and scientists working on the design and manufacturing of parts used in a variety of industries. In the field of medical implants\, Metron A.E. participated in a variety of custom implants programs together with other world leading companies in the field.
URL:https://staging.medilinkmidlands.com/event/webinar-additive-manufacturing-3d-printing-special-interest-group-sig/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/gareth_probert2.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210923T100000
DTEND;TZID=Europe/London:20210923T113000
DTSTAMP:20260421T222838
CREATED:20210729T114030Z
LAST-MODIFIED:20210729T114030Z
UID:18732-1632391200-1632396600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Infectious Diseases Special Interest Group - The Microbiome: Emerging and Innovative Technologies
DESCRIPTION:Join the next online Infectious Diseases Special Interest Group (SIG)\, this SIG will focus on “The Microbiome: Emerging and Innovative Technologies”. \nRecent advances in microbiome research have highlighted the significant influence these microbial populations have on our wellbeing. The upcoming SIG will be focussing on this rapidly accelerating field\, looking at the role of the microbiome in human health and how imbalances lead to disease. It will also look at the application of emerging technologies that can be used to better understand the microbiome\, and the development of new therapeutic approaches for associated diseases. \nThis event is in partnership with De Montfort University and led by Dr Katie Laird\, Professor of Microbiology and also Head of the Infectious Disease Research Group at De Montfort University. \nConfirmed speaker presentations:\n– Open Innovation in Biofilms R&D: Translation of Academic Research to Address Industry Needs\n– Manipulating respiratory microbiomes: a role for commensals?\n– Labskin: Commercial Skin models to understand the microbial/host interaction\n– Rapid Prototyping of Microfluidic Systems \nDURATION: 1.5 hours \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire region and is open to all. \nSpeaker Profiles: \n\nDr Katie Laird\, Professor of Microbiology and Head of the Infectious Disease Research Group at Leicester School of Pharmacy\, De Montfort University \nKatie has a BSc (Hons) in Biology and obtained a PhD in applied microbiology in 2008. During her PhD she developed and patented an essential oil based antimicrobial vapour\, whilst her postdoctoral work included the assessment of natural antimicrobials efficacy against post-harvest pathogens.\nHer research interests include the use of natural products as antimicrobials in particular to combat hospital acquired infections and biofilms.  Her other area of research includes the assessment of healthcare laundry as a potential route of cross contamination in the clinical arena. \n\nDr Katerina Steventon\, Senior Innovation Consultant\, National Biofilms Innovation Centre\nKaterina is a healthcare specialist with substantial experience of working at the clinical\, commercial and research interface. She holds a MSc in Clinical Biochemistry\, a PhD in Transdermal Absorptions and over 20 years of global work experience in the personal care and wound care industry. Katerina has an in-depth knowledge of skin biology in both its healthy and diseased states. The strengths Katerina brings to NBIC comprise a comprehensive understanding of the industry and academia\, commercialisation of research in a spectrum of healthcare areas and an experience of running an innovation consultancy with a focus on functional skincare.\n \n\nDr David Cleary\, Career Track Post-Doctoral Fellow\, Faculty of Medicine\, University of Southampton and the Southampton NIHR Biomedical Research Centre\nDavid graduated in Medical Microbiology from the University of Surrey in 2002 and went on to complete his PhD with the University of Warwick whilst employed as a microbiologist at the Defence Science and Technology Laboratories (DSTL)\, Porton Down. His current research interests include characterising human respiratory tract microbiomes to determine the microbiota-host interactions that determine colonisation and progression to disease\, as well as understanding the epidemiology of pathogens such as Streptococcus pneumoniae and Non-typeable Haemophilus influenzae. \n\nDr David Caballero-Lima\, Head of R&D\, Labskin\nDavid received his undergraduate degree in Biology and his PhD in Biomedical Sciences from the Universidad de Extremadura in Spain. David took postdoctoral research positions at the University of Sheffield and the University of Manchester\, with both roles focussing on studying human/pathogen interaction via tissue models and obtaining a greater understanding in the regulation of the cell cycle and vesicle transportation during morphological changes.\nDavid was initially Services Manager at Labskin\, bringing his 18 years’ experience working with microbiology and host-pathogen interactions.  As Head of R&D\, David now leads the research department\, focusing on the development of new methods for studying the native skin microflora\, prebiotic\, probiotics and antimicrobial effects of ingredients and formulation for pharmaceutical and cosmeceutical studies. He is also the scientific lead for the development of Labskin new consumers service; Skin Trust Club. David is a key collaborator on international research bids\, as a peer with leading international experts from academia and industry. \n\nPaul Marshall\, Engineering Consultant\, Co-Founder of Rapid Fluidics Ltd\nAn experienced Chartered Mechanical Engineer\, Paul lead the engineering for QuantuMDx Ltd in Newcastle to develop the Q-POC point of care mobile diagnostics system and is now an engineering consultant specialising in Life Sciences. His works covers a wide range of projects from microfluidic instrumentation and consumable systems design for diagnostics through to technical reviews of water\, sanitation and health projects for the Bill and Melinda Gates Foundation. \n\nDr Raymond Allan\, Senior Lecturer in Microbiology\, De Montfort University\nRaymond’s research focusses on the investigation of bacterial biofilms\, developing an understanding of the adaptive mechanisms they employ to enable their survival within the human host\, and their role in chronic infectious disease. His research also includes the identification of targets for the development and investigation of novel treatment strategies for biofilm-associated infections. He has several years’ experience investigating biofilms at University of Southampton\, the National Biofilms Innovation Centre\, and Southampton NIHR Wellcome Trust Clinical Research Facility\, before joining De Montfort University. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-infectious-diseases-special-interest-group-the-microbiome-emerging-and-innovative-technologies/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/David-Caballero.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210928T090000
DTEND;TZID=Europe/London:20210929T170000
DTSTAMP:20260421T222838
CREATED:20200108T143521Z
LAST-MODIFIED:20200108T143521Z
UID:18052-1632819600-1632934800@staging.medilinkmidlands.com
SUMMARY:Med-Tech Innovation Expo 2021
DESCRIPTION:Medilink UK is working closely with Rapid News\, organisers of Med-Tech Innovation Expo. Plans are continuously being worked on to provide a safe environment for both exhibitors and visitors. We continue to plan ahead\, and continue to monitor all Government guidelines.\n\nMed-Tech Innovation Expo is the UK & Ireland’s leading event for medical design and manufacturing technology. Discover the latest machines\, technology\, products and services while networking with designers\, engineers\, innovators and manufacturers from across the medical and healthcare sector.\nHear from industry leaders\nMed-Tech Innovation Conference\, in association with Medilink UK. The Med-Tech Innovation Conference is now the UK’s key annual summit for medical device OEMs\, with a programme that offers high-level thought leadership from the sector’s biggest names.  Produced by Medilink UK\, the Conference stage has played home in the past to leading figures from Boston Scientific\, Roche Diagnostics\, NHS England\, Innovate UK\, and the MHRA to name just a few.\nLearn about the regulatory and market access challenges and opportunities from those with senior-level insights. Take the opportunity to question policymakers and influencers\, and network with a first-class line up of speakers. \nExhibit – increase visibility\, credibility and sales\n– Your stand is the platform to generate hot new leads and engage with existing customers; accelerating your sales process and supporting business growth plans. Visitors are highly engaged\, many with direct purchasing power and the intention to do business on the day. \n– With thousands of visitors from the medical engineering\, design and manufacturing community\, you will meet decision makers and influencers from designers and project engineers to research and development and production professionals. \n– As an exhibitor\, you will have the opportunity to increase brand awareness\, boost your profile in the industry\, meet suppliers who will help your business grow and learn about innovative new developments in the world of medical technology.\nMedilink members receive a 15% discount on exhibition stands \nCurrent confirmed Medilink members exhibiting as part of the Medilink UK Pavilion\, B70/B88:\n– Accelerate Associates\n– BHIB Insurance Brokers Ltd\n– Bluefrog Design\n– Commala Ltd\n– Kaleidoscope Data Privacy Consultants\n– Lucid Group\n– Oxford Product Design\n– The Leicester Life Sciences Accelerator \nYou will find many other Medilink members exhibiting throughout the expo\, along with the Medilink UK stand – B80\, so please come along and catch up with the Medilink team. \nClick here to view the current online interactive expo floor plan. \n*****Limited pod spaces still available on Medilink UK Pavillion exhibition stand******* \nTo find out more on exhibiting please click here to email Sarah Orme\, Rapid News. \nFind out more on the show and the benefits click here
URL:https://staging.medilinkmidlands.com/event/med-tech-innovation-expo/
LOCATION:NEC Birmingham\, Hall 2\, Birmingham\, B40 1NT\, United Kingdom
CATEGORIES:Medilink Partner Event
END:VEVENT
END:VCALENDAR